Loss of SOCS3 expression is associated with an increased risk of recurrent disease in breast carcinoma

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2010-02-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-010-0819-6PMID 20155426PMCID PMC11827955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumorigenesis and Neoplastic Progression Stat 3 Promotes Metastatic Progression of Prostate Cancer

  2010cited by this paper
• SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL

  2009cited by this paper
• Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy.

  2009cited by this paper
• The evolution of lymph node assessment in breast cancer

  2009cited by this paper
• SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases

  2009cited by this paper
• Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.

  2008cited by this paper
• Decreased expression of SOCS-3 mRNA in breast cancer with lymph node metastasis.

  2008cited by this paper
• Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3

  2008cited by this paper
• SOCS‐3 is associated with vascular invasion and overall survival in hepatocellular carcinoma

  2008cited by this paper
• Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme

  2008cited by this paper
• Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway*

  2008cited by this paper
• Prognostic Value of Signal Transducers and Activators of Transcription 3 in Breast Cancer

  2008cited by this paper
• Methylation status of the SOCS3 gene in human malignant melanomas.

  2007cited by this paper
• Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.

  2007cited by this paper
• Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.

  2007cited by this paper
• Positive and negative roles of IL-6, STAT3, and SOCS3 in inflammatory arthritis.

  2007cited by this paper
• Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis.

  2006cited by this paper
• Inhibition of Growth and Metastasis of Human Hepatocellular Carcinoma by Antisense Oligonucleotide Targeting Signal Transducer and Activator of Transcription 3

  2006cited by this paper
• Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma

  2006cited by this paper
• STAT3-mediated constitutive expression of SOCS3 in an undifferentiated rat trophoblast-like cell line.

  2006cited by this paper
• SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition

  2005cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• Regulation of cytokine signaling by SOCS family molecules.

  2003cited by this paper
• SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation

  2003cited by this paper
• SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer

  2003influential reference
• Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

  2002cited by this paper
• SOCS-1 participates in negative regulation of LPS responses.

  2002cited by this paper
• Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3

  2001cited by this paper
• Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

  2001cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• Negative regulators of cytokine signal transduction

  1999cited by this paper
• Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.

  1997cited by this paper

• Computational analysis of functional, structural and pathogenic impacts of missense SNPs in the human SOCS3 gene.

  2025cites this paper
• Genotypic and haplotype analysis of SOCS3 gene polymorphisms (rs4969169, rs12953258, rs1061489) in association with clinicopathological factors in breast cancer

  2025cites this paper
• E3 ligase SOCS3 regulates NOD2 expression by ubiquitin proteasome system in lung cancer progression.

  2023cites this paper
• Increased SOCS1 and SOCS3 expression in papillary thyroid carcinoma and its association with prognosis.

  2023cites this paper
• Structure-Activity Relationship Investigations of Novel Constrained Chimeric Peptidomimetics of SOCS3 Protein Targeting JAK2

  2022cites this paper
• Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives

  2022cites this paper
• Prognostic Significance of SOCS3 in Patients With Solid Tumors: A Meta-Analysis

  2022cites this paper
• Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer

  2021cites this paper
• Cross-talk between myeloid-derived suppressor cells and Mucin1 in breast cancer vaccination: On the verge of a breakthrough.

  2020cites this paper
• Benzimidazole and acetamide derivatives as potential therapeutic agent for breast cancer

  2019cites this paper
• Human epidermal growth factor receptor 2 expressions and Janus-activated kinase/signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway may be associated with clinicopathological features and prognosis of gastric cancer

  2018cites this paper
• Mimetics of suppressor of cytokine signaling 3: Novel potential therapeutics in triple breast cancer

  2018cites this paper
• The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma

  2018cites this paper
• Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non- small-cell lung cancer.

  2017cites this paper
• SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

  2016cites this paper
• Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer

  2016cites this paper
• Phosphorylation of STAT3 in Undifferentiated Pleomorphic Sarcoma Is Correlated with a Favorable Prognosis

  2016cites this paper
• Prognostic significance of STAT3/phosphorylated-STAT3 in tumor: a meta-analysis of literatures.

  2015cites this paper
• Novel endogenous angiogenesis inhibitors and their therapeutic potential

  2015cites this paper
• SOC3 in Bladder Carcinoma in Relation to Proinflammatory Cytokines and Tumor Histopathological Grading

  2015cites this paper
• Significance of suppressor of cytokine signaling-3 expression in bladder urothelial carcinoma in relation to proinflammatory cytokines and tumor histopathological grading.

  2015cites this paper
• SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model

  2014cites this paper
• Mechanisms of vascular disease: divergent roles for suppressor of cytokine signaling 3 in angiotensin II-induced vascular dysfunction

  2014cites this paper
• Loss of Suppressors of Cytokine Signaling 3 Promotes Aggressiveness in Hepatocellular Carcinoma

  2014cites this paper
• Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis

  2013cites this paper
• Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer

  2013cites this paper
• SOCS3 is an endogenous inhibitor of pathologic angiogenesis.

  2012cites this paper
• Loss of Expression and Function of SOCS3 Is an Early Event in HNSCC: Altered Subcellular Localization as a Possible Mechanism Involved in Proliferation, Migration and Invasion

  2012cites this paper
• Effects of 5-fluorouracil and gemcitabine on a breast cancer cell line (MCF-7) via the JAK/STAT pathway.

  2012cites this paper
• Suppressor of Cytokine Signaling 3 Inhibits Breast Tumor Kinase Activation of STAT3*

  2012cites this paper
• Signal transducers and activators of transcription-from cytokine signalling to cancer biology.

  2011cites this paper
• A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

  2011cites this paper
• Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma

  2011cites this paper
• SOCS3 promoter methylation is mutually exclusive to EGFR amplification in gliomas and promotes glioma cell invasion through STAT3 and FAK activation

  2011cites this paper
• Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in hepatocellular carcinoma.

  2011cites this paper
• gp130 at the nexus of inflammation, autoimmunity, and cancer

  2010cites this paper